To date, more than 180 patients have prescribed to the CTN program, with 80% of those patients residing in Windsor-Essex. Of this local patient population, 25% are either now enrolled in a clinical trial or are awaiting enrollment, a dramatic increase in local patient access to clinical trials.
The project's current goal is to contribute in the maximization of benefits within the CTN program and to reduce the challenges associated with clinical trial enrollment. In the near future, the focus will be to improve the clinical trials matching system by developing enhanced computer platforms, thus increasing aid patient and improving patient outcomes.
This project highlights the importance of local seed funding. The WE-SPARK Igniting Discovery grant sponsored by the Cancer Research Collaboration Fund allowed Dr. Hamm and Dr. Cavallo-Medved to gather preliminary data and bring together a strong multidisciplinary collaborative team of local researchers and Medical students to apply for national grants.